ORCID: https://orcid.org/0000-0001-8498-0736; Frasheri, Iris
ORCID: https://orcid.org/0000-0003-1632-6585; Heck, Katrin; Scalia, Carla; Pitchika, Vinay; Summer, Burkhard; Ern, Christina; Heym, Richard; Schwendicke, Falk
ORCID: https://orcid.org/0000-0003-1223-1669; Bumm, Caspar Victor
ORCID: https://orcid.org/0000-0003-0681-1528 und Folwaczny, Matthias
(10. November 2025):
A Study Into Systemic and Oral Levels of Proinflammatory Biomarkers Associated With Endpoints After Active Non‐Surgical Periodontal Therapy.
In: Journal of Clinical Periodontology, Bd. 52, Nr. 2: S. 188-198
[PDF, 714kB]

Abstract
Aim:
To analyse whether some selected inflammatory biomarkers collected from venous blood and gingival crevicular fluid (GCF) were associated with the outcome of non-surgical periodontal therapy.
Materials and Methods:
Two-hundred and nine patients affected by periodontitis were enrolled in the study, who had undergone steps I and II therapy as well as a non-surgical re-instrumentation (NSRI) of periodontal pockets after 6 months. Serum (SE), plasma (PL) and GCF samples were quantitatively analysed for the following inflammatory biomarkers: active matrix metalloproteinase-8 (aMMP-8), prostaglandin E2 (PGE2) and surfactant protein D (SP-D). Therapy outcomes were evaluated using a ‘treat-to-target’ endpoint (T2T) at the patient level, defined as ≤ 4 sites with pocket depth ≥ 5 mm.
Results:
Patients presented with 23 ± 6 teeth (mean ± SD) at baseline. After steps I and II therapy, 41.6% of the patients reached T2T and after NSRI 47.4%. Univariate analysis identified a potential association between high levels of PL-SP-D and more favourable treatment outcomes. Multivariate binary logistic regression adjusted for sex, mean baseline probing depth, diabetes and current smoking status confirmed an independent relationship between baseline PL-SP-D and the T2T after steps I and II therapy (aOR 0.432, p = 0.011), implying that a higher level PL-SP-D at baseline is associated with a > 50% reduced risk of failing T2T. However, no such association was found for PL-SP-D and NSRI.
Conclusion:
Higher baseline PL-SP-D levels might be associated with more favourable treatment outcomes after steps I and II therapy. This may be due to its role in the regulation of neutrophil function. However, further investigation is required to confirm this hypothesis. If proven, PL-SP-D could play a role as a biomarker for identifying individuals who respond differentially to primary therapy.
Dokumententyp: | Zeitschriftenartikel |
---|---|
Fakultät: | Medizin > Klinikum der LMU München > Poliklinik für Zahnerhaltung und Parodontologie |
Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
URN: | urn:nbn:de:bvb:19-epub-125584-3 |
ISSN: | 0303-6979 |
Sprache: | Englisch |
Dokumenten ID: | 125584 |
Datum der Veröffentlichung auf Open Access LMU: | 29. Apr. 2025 05:38 |
Letzte Änderungen: | 29. Apr. 2025 05:38 |